Comprehensive Self-management Support for COPD Patients
SAMBA COPD
Comprehensive Home-based Self-management Support for COPD Patients
2 other identifiers
interventional
59
1 country
1
Brief Summary
The study team will adapt and expand an effective model of asthma self-management support for patients with chronic obstructive pulmonary disease (COPD). In this new model, community health workers will comprehensively screen for and address barriers to effective COPD self-management, including maladaptive coping behaviors, and guide patients through home-based pulmonary rehabilitation. Feasibility of the new model will be assessed in preparation for a fully powered, multisite randomized trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2020
CompletedFirst Submitted
Initial submission to the registry
August 27, 2020
CompletedFirst Posted
Study publicly available on registry
August 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2022
CompletedResults Posted
Study results publicly available
September 28, 2023
CompletedSeptember 28, 2023
September 1, 2023
1.7 years
August 27, 2020
August 11, 2023
September 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
COPD Assessment Test (CAT)
The COPD Assessment Test (CAT) is a validated measure designed to measure the impact of COPD on a person's life, and how this changes over time. Full range from 0-40, higher scores indicates a more severe impact of COPD on a patient's life.
Baseline and 6 months
Secondary Outcomes (6)
Number of Participants With Medication Adherence Report Scale (MARS) Score ≥4.5
Baseline and 6 months
Exercise Tolerance - 6 Minute Walk Test
Baseline and 6 months
Physical Activity Adult Questionnaire (PAAQ)
Baseline and 6 months
Number of Participants With Hospitalizations
Baseline and 6 months
Number of Participants With ED Visits
Baseline and 6 months
- +1 more secondary outcomes
Study Arms (2)
Targeted self-management barrier support
EXPERIMENTALIntervention group - Targeted self-management barrier support, home-based pulmonary rehabilitation, and emergency medication with community health workers
Guided COPD education
ACTIVE COMPARATORControl group - Guided COPD education with a COPD educator
Interventions
For the intervention, community health workers will assess barriers to good self-management behaviors that lie within 4 domains: 1) social context, 2) physical health and functioning, 3) cognitive factors, and 4) psychological factors. They will work with participants for 6 months to help them work through their barriers to self-management of COPD. Participants can also participate in home-based pulmonary rehabilitation and can receive emergency pack/action pack medication for COPD exacerbations.
The attention control will consist of 4 visits by a COPD educator to the home to review the COPD education booklet. During the first visit, this COPD educator will review the COPD 1-2-3 booklet in its entirety with the patient. During visits 2 and 3, the COPD educator will make a visit to "check in" with the patient, ask how they are doing with their respiratory symptoms, and review any sections of the COPD 1-2-3 booklet the patient chooses. The COPD educator will recommend visits every 2 months but the patient and COPD educator may choose to modify the interval as needed. If the patient appears to be experiencing worsening respiratory symptoms during any visit, the COPD educator will notify the patient's physician.
Eligibility Criteria
You may qualify if:
- Age \>40 years
- Chart-document severe or very severe COPD (FEV1\<50% predicted) or COPD-related ED/hospitalization ≥ 1 visit within the past 12 months
- Prescribed any daily medication for COPD, English or Spanish speaking, Smoking history ≥ 10 pack-years
You may not qualify if:
- Diagnosis in the clinical record of dementia, because the study focuses on patients with capacity to independently perform self-management tasks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinailead
- City Health Workscollaborator
- Northwestern Universitycollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Related Publications (3)
Federman AD, Barry M, Moas E, Davenport C, McGeough C, Tejeda M, Rivera L, Gutierrez S, Mejias H, Belton D, Mathew C, Lindenauer PK, McDermott D, O'Conor R, Wolf MS, Wisnivesky JP. Protocol for a feasibility randomized trial of self-management support for people with chronic obstructive pulmonary disease using lay health coaches. Contemp Clin Trials. 2021 Nov;110:106570. doi: 10.1016/j.cct.2021.106570. Epub 2021 Sep 21.
PMID: 34560265DERIVEDPoot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.
PMID: 34495549DERIVEDCox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.
PMID: 33511633DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Alex D. Federman, MD, MPH
- Organization
- Icahn School of Medicine at Mount Sinai
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Research coordinators (RCs) and investigators are blinded to study randomization and treatment arm for each participant.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Research
Study Record Dates
First Submitted
August 27, 2020
First Posted
August 31, 2020
Study Start
August 24, 2020
Primary Completion
April 28, 2022
Study Completion
April 28, 2022
Last Updated
September 28, 2023
Results First Posted
September 28, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data collected during the trial will not be shared.